C1q/TNF-related Proteins in Coronary Artery Disease

计划入组 362 人 · 首次发布于 2014 年 3 月 11 日

CTRP3 and Progranulin in Patients With Coronary Artery Disease

计划入组 362 人 · 首次发布于 2013 年 6 月 5 日

C1q/TNF-related Proteins in Non-Alcoholic Fatty Liver Disease

计划入组 500 人 · 首次发布于 2014 年 3 月 11 日

C1Q inhibitor(Abzyme Therapeutics)

C1q tumor necrosis factor related protein 1(ZymoGenetics, Inc.)

Protein C(Balfaxar, Beriplex, Ceprotin, Kcentra, Octaplex)

Protein Sciences Corporation

United States

HOUSE OF SUPPLEMENTS AUSTRALIA PTY LTD

Australia

Sanofi-Aventis Deutschland Gmbh

Sweden

Annexon's Tanruprubart Shows Rapid and Durable Improvements in Guillain-Barré Syndrome Phase III Trial

Annexon Presents Phase 2 ARCHER Data Demonstrating ANX007's Vision and Photoreceptor Protection in Geographic Atrophy

Annexon Biosciences' ANX005 Shows Promise in Guillain-Barré Syndrome Treatment